Opportunity PAR-06-449

The summary for the Opportunity PAR-06-449 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Opportunity PAR-06-449: -The goal of the Paul Calabresi Award for Clinical Oncology (PCACO) is to ensure a cadre of medical doctors and basic science researchers who can collaborate with each other to design and implement hypothesis-based translational therapeutic research. -The purpose of the PCACO is to increase the number of medical doctors (M.D. s, D.O. s), and doctorally-degreed nurses (Ph.D. s or equivalents) and basic research scientists (Ph.D. s, D.V.M. s, or equivalents) who are highly-motivated and trained to: 1) primarily perform clinical oncology therapeutic research that develops and tests scientific hypotheses based on fundamental and clinical research findings; 2) design and test hypothesis-based, clinical therapeutic protocols and adjunct biological analyses and for clinician candidates to administer all phases (i.e., pilot/Phase I, Phase II, and Phase III) of cancer therapeutic clinical trials, and (3) conduct cancer therapeutic research in team research settings in which basic research and clinical scientists collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will emphasize the use of animal or other model systems. -The PCACO application may be submitted on behalf of the program leader (principal investigator or PI) by for-profit or non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; and domestic institutions or organizations. Foreign institutions are not eligible to apply.

Federal Grant Title:	Opportunity PAR-06-449
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-06-449
Type of Funding:	Grant
CFDA Numbers:	93.398
CFDA Descriptions:	Cancer Research Manpower
Current Application Deadline:	Jul 12, 2010 Mult
Original Application Deadline:	Jul 12, 2009 Multi
Posted Date:	Jun 08, 2006
Creation Date:	Jul 10, 2009
Archive Date:	Aug 13, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. All clinician and basic science Ph.D. scholars must satisfy the following additional requirements: Special Requirements Other training programs: Where there already exists an active Ruth L. Kirschstein (T32) National Research Service Award (NRSA) or other institutional career development program (e.g., NCI and NIH Roadmap K12, K30, General Clinical Research Core [GCRC] Scholars Program) overlap between these programs must be eliminated and/or the NCI Paul Calabresi Award for Clinical Oncology (K12) structured in a way to complement and take advantage of these other career development/training programs. This may require merging components of other programs with the NCI K12 or linking curriculum programs (e.g., K30) with the core requirements of the NCI K12. Institutions require NCI approval to submit an application if another NCI K12 exists at the institution. Institution: The institution must have substantial support for peer-reviewed basic science and clinical research and an adequate number of faculty qualified in patient-oriented therapeutic research, translational research, and basic science cancer research to serve as mentors in the proposed Program. Environment: The research environment should be one in which there are active basic science/clinical research collaborations that exemplify a dynamic two-way exchange of information and ideas between basic science research and clinical scientists. Special Program Requirements Program Management: The PI must use an Advisory Committee (AC) to provide an oversight function and annual evaluation of the Program as a whole. The committee's responsibilities should include but are not limited to: selecting clinician, nurse, and basic science scholars (Note: basic science scholars are encouraged as part of these Programs but they are optional), assigning preceptors, approving each scholar's career development plan, evaluating each scholar's progress, authorizing the termination of a scholar who is not performing adequately, monitoring the overall effectiveness of the program and recommending mid-course changes when needed. A detailed description of the committee's composition, function, and frequency of meetings should be provided. See Program Announcement for more information.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional); • NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Inde...; • NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Inde...; • NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Inde...; • Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Tr...; • NCI Transition Career Development Award to Promote Diversity; • Cancer Education (R25E) Grants Program; • Cancer Prevention, Control, Behavioral and Population Sciences Career Development Award
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...